Laura Gault
Directeur Technique/Scientifique/R&D chez SAGE THERAPEUTICS, INC.
Fortune : 2 465 $ au 30/06/2024
Profil
Laura Gault is currently the Chief Medical Officer at SAGE Therapeutics, Inc. Prior to her current position, she worked as the Vice President at Alexion Pharmaceuticals, Inc. from 2019 to 2022 and as the Vice President-Neurology Clinic Development at Vertex Pharmaceuticals, Inc. from 2017 to 2019.
Gault received her undergraduate degree from the University of Pittsburgh and her doctorate from Case Western Reserve University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SAGE THERAPEUTICS, INC.
0,00% | 31/03/2024 | 227 ( 0,00% ) | 2 465 $ | 30/06/2024 |
Postes actifs de Laura Gault
| Sociétés | Poste | Début |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/10/2022 |
Anciens postes connus de Laura Gault
| Sociétés | Poste | Fin |
|---|---|---|
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2022 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/03/2019 |
Formation de Laura Gault
| Case Western Reserve University | Doctorate Degree |
| University of Pittsburgh | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
